IntelGenx Tech Corp (fka IGXT)

[specular]

That was frighteningly bad - even scary.

Zerbe was completely unprepared - he didn't even know the status of the Suboxone PAR project (which is on their web site thank you).

Migraine revenue will not start until 2016 - with his FDA approval projection of late 2015. Then he has the nerve to blame the existing supplier for the problem, and tells them 'to get their act together'. No Horst that responsibility is on IGXT in terms of running independent audits on your suppliers. This screw-up is on you.

So much potential - he should really go to PAR and ask them what they would give him for the company. I know it would be pennies on the dollar for what it would be worth had they executed properly on the business side - but that reality will never happen. They are years away from any meaningful revenue. What an incredible waste of an amazing technology / business opportunity.